Alanbell Health Tech Group Named Among Top 5 Precision Health Management Companies in 2024 Future Healthcare 100 Awards

With the profound transformation of China's social structure, the dual pressures of population aging and chronic diseases have become increasingly prominent, bringing unprecedented challenges and opportunities to China's health management industry. In response to the surging demand for health monitoring and prevention among the elderly and specific populations, the stateThe 14th Five-Year Plan explicitly sets forth the strategic directive of shifting from disease treatment to health management. Advanced technologies such as artificial intelligence, big data, and virtual reality are being deeply integrated into the field of health management. These technologies not only provide more precise and personalized service tools for health management but also inject new vitality into the industry’s innovative development. Meanwhile, with the continuous rise in public health awareness, there is growing attention to healthy lifestyles and disease prevention, offering broad market space and significant development potential for the health management industry.

VCBeat aims to identify innovative enterprises with high growth potential in precision health management services, focusing on two dimensions: medical technology innovation and business model innovation. On the evening of May 9, 2024, VB100 and VCBeat officially announced the 2024 Future Healthcare 100 rankings and unveiled the Top 5 companies in precision health management services.

Alanbell Health Technology Group is a technology-driven innovative medical enterprise established by Jiachen Capital through an industrial incubation model. Adhering to the professional principles of evidence-based medicine, Alanbell integrates cutting-edge concepts from laboratory medicine, clinical medicine, functional medicine, and integrated holistic diagnosis and treatment. By bringing together domestic and international medical talent and technological resources, and operating self-built high-standard laboratories, the company focuses on “quantifiable, visualizable, and manageable” risk management for chronic disease thresholds. Combining a membership system, concierge-style service, and a high-quality ecosystem of medical resources, Alanbell provides highly personalized “Basic-Better-Best” health companionship programs, striving to become a long-term partner in its clients’ health journeys.

· Alanbell Medical Diagnosis and Treatment Center,Bringing together medical experts from leading international institutions such as WellcomeMD and domestic physician teams, we provide intervention and treatment for chronic diseases based on customers’ comprehensive diagnostic indicators. Through scientific preventive management and a dedicated concierge model, we deliver customized “holistic health” services to individuals and families, aiming to “prevent disease before it occurs.” Our goal is to enhance customers’ quality of healthy life and extend their healthspan.

·Alanbell Medical Testing in ProgressHeart，Founded under the leadership of Dr. Joseph P. McConnell, former Director of the Cardiovascular Laboratory at Mayo Clinic in the United States, it has introduced globally leading testing equipment and algorithm technologies. It is committed to providing specific and differentiated tests for the prevention, early diagnosis, and management of various chronic diseases, and collaborates with Alanbell Medical Diagnosis and Treatment Center to build a Chinese chronic disease management database.

Mr. Yu Jun, CEO of Alanbell Health Technology GroupInvited to attend the “Forum on Health Management and Innovative Development of Health Insurance,” he delivered a keynote speech on “Digital Health and Integrative Medicine in the Intervention and Management of Chronic Diseases and Aging.” He shared that the future development trend of healthcare will focus on addressing the challenges of chronic diseases and aging, with precision medicine likely becoming mainstream. People’s demands will increasingly center on disease prevention and extending life expectancy, while virtual care and telemedicine will be widely adopted. Digitalization and artificial intelligence will also become essential tools empowering personalized medicine.

In his view, chronic disease management is not merely the management of a single disease. Chronic diseases cause not only damage to individual organs but also trigger systemic, multi-organ interactions—where a change in one part affects the whole—entailing complex management and polypharmacy issues. Centered on integrative medicine as its core health solution, Alanbell develops personalized, comprehensive care plans that facilitate interdisciplinary team collaboration. It focuses not only on the disease itself but also prioritizes the patient’s overall condition and needs, helping clients enhance their quality of life, extend longevity, and sustainably reap the benefits of effective health management.

Dr. Guo Peng, Chief Medical Officer of Alanbell Health Technology GroupInvited to participate in a roundtable discussion, Dr. Guo Peng engaged with on-site experts on the topic of “How Health Insurance and Health Management Can Achieve Localized Integration.” According to Dr. Guo Peng, among Chengdu Alanbell Health Management Co., Ltd.’s client base, the three most demanded services by mid-to-high-net-worth individuals are customized health check-up plans, coordinated family health management, and daily medical consultations. For commercial insurance clients, especially high-net-worth individuals, personalized health management is becoming increasingly important and can also help reduce the risk of critical illness claims payouts.

In China, the traditional specialty-based medical model remains focused on treating established diseases through disease-specific consultations, failing to meet holistic health needs. Many seemingly negligible “minor ailments” outlined in medical guidelines are, in fact, the root causes of suboptimal health status and may, over time, develop into serious conditions that patients deeply regret. In recent years, a growing number of individuals have recognized the importance of health management but lack effective means to understand and manage their family’s health. Against this backdrop, Alanbell’s integrated model combining general practitioner family doctors with integrative medicine has emerged, offering multi-level, comprehensive healthcare management services.

Technological transformation is breaking through traditional industrial boundaries, endowing Chinese healthcare professionals with new missions and significance in this new era. VCBeat also hopes that more enterprises will uphold the pioneering spirit of medical innovation, jointly deepen their engagement in health management and digital healthcare, contribute to the construction of future healthcare structures, and drive the innovative transformation of the health and medical industry.

1. Six Key Areas of Technological Innovation:

Genomics/Biomarker Testing: In-depth Analysis of Individual Molecular Profiles;

Intelligent Imaging-Assisted Diagnosis: AI-Based High-Precision Pathological Analysis;

Health Early Warning and Monitoring Platform: Aggregates multi-source health data for risk prediction and intervention;

Intelligent Medical Robots: Used in clinical scenarios such as diagnosis and surgery;

Intelligent Health Monitoring Devices: Rapid and Efficient Acquisition of Physiological Health Data;

Telemedicine and Home-Based Smart Monitoring: Bringing Healthcare Services into the Home;

2. Seven Key Service Areas:

Hereditary Disease Management: Genetic Testing, Genetic Risk Assessment, etc.;

Full-Cycle Health Management: Early-life health management, including preconception eugenics and molecular-assisted reproduction;

Healthy Aging Services: Screening for Common Geriatric Conditions, Personalized Integrated Medical and Elderly Care Services, etc.;

Sports Rehabilitation and Injury Prevention: Sports Genetic Testing, Intelligent Training Programs, Injury Prevention, etc.;

Precision Management of Chronic Diseases: Pharmacogenetic Testing, Medication Guidance, Remote Monitoring, etc.;

Mental Health Services: Psychological Assessment, Online Intervention, etc.;

Digital Empowerment in Health Management: Intelligent Medical Decision Support, Personalized Health Education, etc.